A Guide to Help You Keep Up With the Omicron Subvariants
How different are the seemingly endless stream of emerging omicron subvariants from one another and how protected are we?
Search
Filter
Clear All201-220 of 1,120 results
-
-
When It Comes To The New Coronavirus, Just Who Is A ‘Close Contact’?
Health officials stress that the new coronavirus devastating mainland China continues to pose minimal risk in the United States. The exception involves people who have had “close contact” with someone infected with the virus. So what exactly is close contact?
-
Watch: Reviewing Public Health Record Of New Coronavirus Commander Mike Pence
KHN Midwest editor and correspondent Laura Ungar shares her expertise on Vice President Mike Pence’s public health track record as he leads the nation’s novel coronavirus response. Ungar covered a 2015 Indiana HIV outbreak and its fallout amid Pence's tenure as governor.
-
In Face Of Coronavirus, Many Hospitals Cancel On-Site Training For Nursing And Med Students
Hospitals and nursing homes say they are acting to protect students and patients, but nursing educators worry the pipeline of new nurses could be slowed at a time when they may be needed most. Some doctors in training have also seen their clinical rotations canceled.
-
Many Preventive Medical Services Cost Patients Nothing. Will a Texas Court Decision Change That?
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
-
In An Exchange About Coronavirus, Homeland Security Chief Gets Flu Mortality Rate Wrong
The Homeland Security secretary missed the mark with his estimate of the flu's annual U.S. mortality rate.
-
Colorado Moves Toward Statewide Coverage of Wastewater Surveillance
Colorado was among the first states to embrace wastewater testing to track the coronavirus, an important public heath intervention that can give early warning of outbreaks.
-
Biden Falsely Blames Trump Administration For Rejecting WHO Coronavirus Test Kits (That Were Never Offered)
Biden’s statement leaves out context about how countries decided on which test they’d use to identify the presence of the coronavirus.
-
Listen: Updates On Coronavirus Outbreak And How It Affects Chinese Immigrants
California Healthline reporters Anna Maria Barry-Jester and Anna Almendrala spoke with WNHN’s “The Attitude w/ Arnie Arnesen” about the novel coronavirus and its impact on Asian immigrants in the United States.
-
Tech Titans Want the Richest Californians to Pay for Pandemic Preparedness
A measure likely to be on California’s November ballot would tax the state’s wealthiest residents to rebuild crumbling public health infrastructure and try to head off another pandemic. But are inflation-weary Californians willing to vote for new taxes?
By Angela Hart -
Covid Sewage Surveillance Labs Join the Hunt for Monkeypox
Wastewater testing has proved a reliable early alarm bell for covid outbreaks. U.S. researchers are now adapting the approach to track the explosive spread of monkeypox.
-
As The Coronavirus Spreads, Americans Lose Ground Against Other Health Threats
Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.
By Liz Szabo -
Coronavirus Stress Test: Many 5-Star Nursing Homes Have Infection-Control Lapses
Since the beginning of 2017, inspectors have cited more nursing homes for failing to ensure that all workers follow federal prevention and control protocols than for any other type of violation, according to federal records.
By Jordan Rau -
Facts Vs. Fears: Five Things To Help Weigh Your Coronavirus Risk
As the numbers of coronavirus fatalities and infections rise, the threat posed by the outbreak in China can seem frightening. But public health officials say the risk in the United States is low. Experts discuss some important issues that can help U.S. residents understand how the epidemic is unfolding.
By Liz Szabo Au Revoir, Public Health Emergency
Episode 283The Biden administration this week announced it would let the covid-19 public health emergency lapse on May 11, even as the Republican-led House was voting to immediately eliminate the special authorities of the so-called PHE. Meanwhile, anti-abortion forces are pressuring legislators to both tighten abortion restrictions and pay for every birth in the nation. Margot Sanger-Katz of The New York Times, Rachel Roubein of The Washington Post, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness about the rollout of the national 988 suicide prevention hotline.
-
California’s Public Health Tax Is Dead for the Year
A ballot measure that would have taxed California millionaires to boost public health funding will not be on the November ballot. But the tech titans who bankrolled the effort say they are negotiating with Gov. Gavin Newsom’s administration to get more money without imposing new taxes.
By Angela Hart -
Journalists Recap Coverage of the Ongoing Pandemic and Lead Risks in Schools’ Drinking Water
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
First-Person Perspective
No Masking The Best Way To Avoid The Scary Coronavirus: Wash Your Hands
While covering the SARS outbreak as a reporter in China, KHN's editor-in-chief saw that common sense is the best defense against viral illness.
-
Public Health Officials Offer Scant Details On U.S. Coronavirus Patients
To date, the U.S. has multiple confirmed cases of the viral infection that originated in Wuhan, China. That includes cases in which the virus passed from person to person within this country. So why don’t health officials share more information with the public?
-
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
By Arthur Allen and Sarah Jane Tribble